Clinical Trial Update: Long Term Metabolic Safety of Norditropin® Treatment of Small for Gestational Age (SGA) Subjects

View source ↗

Summary

Long-term metabolic safety data from a study of Norditropin in children with Small for Gestational Age have been completed and updated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Restriction
• Small For Gestational Age

Drugs mentioned

• Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Foetal Growth Problem, Small for Gestational Age | Status: COMPLETED